IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion.
Xu B, Sun H, Liu S, Liao L, Song X, Wu Y, Hou Y, Jin W
Oncogene. 2024 Mar;43(10):693-702. doi: 10.1038/s41388-023-02934-w. Epub 2024 Jan 12.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.